News

BioNTech chalks up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine in a phase 2 trial in melanoma.
The summer of 2023 saw the approval of a new treatment option for certain patients with uveal melanoma, a form of cancer that begins in the eye and remains a challenge to treat. Richard Staines ...
Melanoma is the most serious type of skin cancer. It develops when skin cells multiply rapidly as a consequence of mutations in their DNA caused by UV exposure. Melanomas originate in the pigment ...